How often Mark Lipacis’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,082 ratings, compared with the average Wall Street analyst.
Mark Lipacis of Evercore ISI ranks #29 of the 1,000 analysts Exent scores, with a 5.0★ rating and a focus on technology. Over a 7‑year lookback, 56.9% of Mark’s price targets were reached, 4.5 points above the 52.4% average across all analysts.
| Metric | Mark Lipacis | All analysts |
|---|---|---|
| Price‑target hit rate | 56.9% | 52.4% |
| Median days to hit target | 87 days | 91 days |
| Calls up after 12 months | 66.5% | 64.0% |
| Median 12‑month return of calls | +21.1% | +13.4% |
| Hit rate, last 2 years | 72.5% | — |
| Average worst drop after a call | −21.1% | — |
| Ratings in the sample | 1,082 | — |
| Stocks covered | 37 | — |
| Time to reach the target | Mark Lipacis |
|---|---|
| Under 30 days | 18.4% |
| 30–90 days | 32.6% |
| 90–180 days | 26.4% |
| Over 180 days | 22.6% |
Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.
In the past year Mark’s ratings were 94% Buy, 6% Hold and 0% Sell.
| Date | Stock | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 3, 2026 | AVGO | Reiterated: Buy | Buy | $578.00 |
| Sep 2, 2026 | CRDO | Reiterated: Buy | Buy | $292.00 |
| Aug 27, 2026 | NVDA | Reiterated: Buy | Buy | $465.00 |
| Aug 12, 2026 | QNT | Reiterated: Buy | Buy | $98.00 |
| Aug 12, 2026 | AMAT | Reiterated: Buy | Buy | $700.00 |
| Aug 7, 2026 | MCHP | Reiterated: Buy | Buy | $117.00 |
| Aug 7, 2026 | MTSI | Reiterated: Buy | Buy | $475.00 |
| Aug 7, 2026 | QBTS | Reiterated: Buy | Buy | $37.00 |
| Aug 6, 2026 | GFS | Reiterated: Buy | Buy | $85.00 |
| Aug 5, 2026 | ALAB | Reiterated: Buy | Buy | $452.00 |
| Aug 5, 2026 | AMD | Reiterated: Buy | Buy | $579.00 |
| Aug 4, 2026 | ON | Reiterated: Buy | Buy | $137.00 |
Live ratings from Mark Lipacis and the other top‑ranked analysts, and the stocks where they agree, are in Exent Stocks Radar.
Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 13, 2026. How accurate are analyst price targets overall?
Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.
By Exent’s scoring Mark Lipacis ranks #29 of 1,000 with a 5.0★ rating. 56.9% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 66.5% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.
Mark Lipacis’s success rate is 70.3% by the ranking source and 56.9% by Exent’s price-target hit-rate backtest, with a median of 87 days to reach a target.
Mark Lipacis (Evercore ISI) covers 37 stocks, mostly in technology. The most frequently rated are NVDA, AMD, MRVL, TXN, MCHP.
Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.
Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.